{"nct_id":"NCT06136559","title":"A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2023-12-13","start_date_type":"ACTUAL","primary_completion_date":"2032-09-07","primary_completion_date_type":"ESTIMATED","completion_date":"2032-09-07","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}